Literature DB >> 8054374

Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.

E Otto1, A Jones-Trower, E F Vanin, K Stambaugh, S N Mueller, W F Anderson, G J McGarrity.   

Abstract

A replication-competent retrovirus (RCR) was detected by S+/L- assays in three lots of retroviral vector G1Na that were harvested on consecutive days from a single culture of PA317/G1Na producer cells. Using a number of retrovirus-specific primer pairs, it was shown that this RCR was a novel recombinant created by exchanges between G1Na and helper sequence pPAM3 and was not an existing RCR introduced by cross-contamination. Sequencing of clones of DNA amplified in six independent PCR reactions confirmed that the 3' portion of this RCR was composed of retroviral envelope sequences unique to pPAM3 joined to a 3' long terminal repeat (LTR) unique to G1Na. Comparison of pPAM3 and G1Na sequences at the site corresponding to this junction revealed a short segment of patchy nucleotide identity (8 out of 10 bp), suggesting that these helper and vector sequences were joined by homologous recombination. Generation of RCR by exchanges between helper and vector sequences underscores the necessity of testing by efficient methods all retroviral vectors for the presence of RCR before their use. Production of 171 lots (855 liters) of various retroviral vectors that were free of RCR, including 42 lots of G1Na, however, indicates that the combination of exchanges required to generate an RCR are infrequent in this system.

Mesh:

Substances:

Year:  1994        PMID: 8054374     DOI: 10.1089/hum.1994.5.5-567

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  21 in total

1.  DNA methylation of helper virus increases genetic instability of retroviral vector producer cells.

Authors:  W B Young; G L Lindberg; C J Link
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Design of 5' untranslated sequences in retroviral vectors developed for medical use.

Authors:  M Hildinger; K L Abel; W Ostertag; C Baum
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Replication-competent lentivirus analysis of clinical grade vector products.

Authors:  Kenneth Cornetta; Jing Yao; Aparna Jasti; Sue Koop; Makhaila Douglas; David Hsu; Larry A Couture; Troy Hawkins; Lisa Duffy
Journal:  Mol Ther       Date:  2010-12-21       Impact factor: 11.454

4.  A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences.

Authors:  H Chong; W Starkey; R G Vile
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 5.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

6.  Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients.

Authors:  Katherine T Marcucci; Julie K Jadlowsky; Wei-Ting Hwang; Megan Suhoski-Davis; Vanessa E Gonzalez; Irina Kulikovskaya; Minnal Gupta; Simon F Lacey; Gabriela Plesa; Anne Chew; J Joseph Melenhorst; Bruce L Levine; Carl H June
Journal:  Mol Ther       Date:  2017-10-20       Impact factor: 11.454

7.  Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products.

Authors:  Kenneth Cornetta; Lisa Duffy; Cameron J Turtle; Michael Jensen; Stephen Forman; Gwendolyn Binder-Scholl; Terry Fry; Anne Chew; David G Maloney; Carl H June
Journal:  Mol Ther       Date:  2017-09-12       Impact factor: 11.454

8.  Marker gene transfer into leukapheresis preparations containing hematopoietic progenitor cells: application in high-dose therapy rescued by reinfusion of peripheral blood hematopoietic progenitors in patients with multiple myeloma.

Authors:  F Herrmann; M Kiehntopf; M A Brach; D Carstanjen; C von Schilling
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

9.  Gene transfer into mammalian cells by a Rous sarcoma virus-based retroviral vector with the host range of the amphotropic murine leukemia virus.

Authors:  E V Barsov; S H Hughes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 10.  The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Authors:  Hervé Perron; Alois Lang
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.